NeoHack Secures Two Patents for Formulations and Methods of Achieving Pain Relief

  • Home
  • Newest Patents
  • Next Generation Treatment
  • Dr. Brown's Blog
  • NeoHack
  • Potential Uses
  • Contact and License
  • Patient Case Studies
  • Resources
  • Alzheimer's Research
  • Understand the Market
  • More
    • Home
    • Newest Patents
    • Next Generation Treatment
    • Dr. Brown's Blog
    • NeoHack
    • Potential Uses
    • Contact and License
    • Patient Case Studies
    • Resources
    • Alzheimer's Research
    • Understand the Market
  • Home
  • Newest Patents
  • Next Generation Treatment
  • Dr. Brown's Blog
  • NeoHack
  • Potential Uses
  • Contact and License
  • Patient Case Studies
  • Resources
  • Alzheimer's Research
  • Understand the Market

NeoHack USA Market Opportunity Exceeds $1.9 Trillion

NeoHack USA Market Opportunity Exceeds $1.9 TrillionNeoHack USA Market Opportunity Exceeds $1.9 TrillionNeoHack USA Market Opportunity Exceeds $1.9 TrillionNeoHack USA Market Opportunity Exceeds $1.9 Trillion

Likely Connections Explained

Alzheimer's, Dimentia

Alzheimer's Annotated Bibliography (pdf)Download
Bethina, et al, Brain derived Neurotrophic Factor Role in Cannabinoid-Mediated Neurogenesis (pdf)Download
Gertsch et al, Beta-caryophyllene is a dietary cannabinoid (pdf)Download
Iskusnyky, et al, Glutathione in Brain Disorders and Aging (pdf)Download
J.W.Kinney, et al, Inflammation as a central mechanism in Alzheimer's disease (pdf)Download
Liang, et al, The Role of NLRP3Inflammasome in Alzheimer's Disease (pdf)Download
Paudel, et al, Impact of HMGB1, RAGE and TLR4 in Alzheimer's (pdf)Download
Vuic, et al, Cannabinoid CB2 Receptors in Neurodegenerative Proteinopathies (pdf)Download

Copyright © 2023 NeoHack Life Sciences, LLC - All Rights Reserved


Powered by

Cookie Policy

This website uses cookies. By continuing to use this site, you accept our use of cookies.

Accept & Close